Heat killed cells of Cryptococcus neoformans var. grubii induces protective immunity in rats: Immunological and histopathological parameters

Medical Mycology

Volumn 44, Issue 6, 2006, Pages 493-504

  Baronetti, José L ^a   Chiapello, Laura S ^a   Aoki, María P ^a   Gea, Susana ^a   Masih, Diana T ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Cryptococcus neoformans; IL10; INF ; Innate immunity; Protection

Indexed keywords

FREUND ADJUVANT; GAMMA INTERFERON; GLUCURONOXYLOMANNAN; INTERLEUKIN 10; NITRIC OXIDE; POLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; COLONY FORMING UNIT; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; DISEASE EXACERBATION; FEMALE; FUNGAL CELL; HISTOPATHOLOGY; IMMUNOLOGICAL PARAMETERS; NONHUMAN; PERITONEUM CELL; RAT; SPLEEN CELL; TH1 CELL;

ANIMALS; ANTIGENS, FUNGAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HEAT; HOT TEMPERATURE; IMMUNITY, CELLULAR; POLYSACCHARIDES; RATS; SPLEEN; T-LYMPHOCYTES; VACCINES, INACTIVATED;

ANIMALIA; CRYPTOCOCCUS NEOFORMANS VAR. GRUBII; FILOBASIDIELLA NEOFORMANS;

EID: 33748620314     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780600750022     Document Type: Article

References (60)

1. Dismukes, WE. (1988) Cryptococcal meningitis in patients with AIDS J Infect Dis, 157, pp. 625-628.
2. Powderly, WG. (1992) Therapy for cryptococcal meningitis in patients with AIDS Clin Infect Dis, 14, pp. 554-559.
3. Spitzer, ED and Spitzer, SG and Freundlich, LF and Casadevall, A. (1993) Persistence of the initial infection in recurrent cryptococcal meningitis Lancet, 341, pp. 595-596.
4. Bloomfield, N and Gordon, MA and Elmendorf, DF., Jr. (1963) Detection of Cryptococcus neoformans antigen in body fluids by latex particle agglutination Proc Soc Exp Biol Med, 114, pp. 64-67.
5. Drouhet, E and Segretain, G. (1951) Inhibition of leukocyte migration in vitro by a capsular polyoside of Torulopsis (Cryptococcus) neoformans Ann Inst Pasteur, 81, pp. 674-676.
6. Pettoello-Mantovani, M and Casadevall, A and Kollmann, TR and Rubinstein, A and Goldstein, H. (1992) Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans Lancet, 339, pp. 21-23.
7. Chiapello, L and Baronetti, J and Aoki, P and (2004) Immunosuppression, interleukin-10 synthesis and apoptosis are induced in rats inoculated with Cryptococcus neoformans glucuronoxylomannan Immunology, 113, pp. 392-400.
8. Murphy, JW. (1993) Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response Infect Immun, 61, pp. 4750-4759.
9. Flesch, IEA and Schawamberger, G and Kaufmann, SHE. (1989) Fungicidal activity of INF-gamma-activated macrophages: Extracellular killing of Cryptococcus neoformans J Immunol, 142, pp. 3219-3224.
10. Levitz, SM and DiBenedetto, DJ. (1988) Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans Infect Immun, 56, pp. 2544-2551.
11. Granger, DL and Perfect, JR and Durack, DT. (1986) Macrophage-mediated fungistasis in vitro: Requirements for intracellular and extracellular cytotoxicity J Immunol, 136, pp. 672-680.
12. Hill, JO and Harmsen, AG. (1991) Intrapulmonary growth and dissemination of an avirulent stain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells J Exp Med, 173, pp. 755-758.
13. Nathan, CF. (1987) Secretory products of macrophages J Clin Invest, 79, pp. 319-326.
14. Rossi, GR and Cervi, LA and Garcia, MM and (1999) Involvement of nitric oxide in protecting mechanism during experimental cryptococcosis Clin Immunol, 90, pp. 256-265.
15. Rossi, GR and Sastre, DA and Rubinstein, HR and Masih, DT. (1994) Biochemical basis for the killing of Cryptococcus neoformans by rat peritoneal cells J Med Vet Mycol, 32, pp. 405-414.
16. Bauman, SK and Nichols, KL and Murphy, JW. (2000) Dendritic cells in the induction of protective and nonprotective anticryptococcal cell-mediated immune responses J Immunol, 165, pp. 158-167.
17. Cherniak, R and Morris, LC and Anderson, BC and Meyer, SA. (1991) Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans Infect Immun, 59, pp. 59-64.
18. Dubois, M and Gilles, KA and Hamilton, JK and Rebers, PA and Smith, F. (1956) Colorimetric method for determination of sugars and related substances Anal Chem, 28, pp. 350-356.
19. Rubinstein, HR and Sotomayor, CE and Cervi, LA and Riera, CM and Masih, DT. (1989) Immunosuppression in experimental cryptococcosis in rats: Modification of macrophage functions by T suppressors cells Mycopathologia, 108, pp. 11-19.
20. Goldman, D and Lee, S and Mednick, A and Montella, L and Casadevall, A. (2000) Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide Infect Immun, 68, pp. 832-838.
21. Goldman, D and Lee, S and Casadevall, A. (1995) Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody Infect Immun, 63, pp. 3448-3453.
22. Goldman, D and Lee, S and Casadevall, A. (1994) Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat Infect Immun, 62, pp. 4755-4761.
23. Mukherjee, J and Scharff, MD and Casadevall, A. (1992) Protective murine monoclonal antibodies to Cryptococcus neoformans Infect Immun, 60, pp. 4534-4541.
24. Rossi, GR and Cervi, LA and Sastre, DA and Masih, DT. (1998) Lack of involvement of nitric oxide in the macrophage-mediated inhibition of spleen cells proliferation during experimental cryptococcosis Clin Immunol Immunopathol, 86, pp. 16-26.
25. Mody, CH and Syme, RM. (1993) Effect of polysaccharide capsule and methods of preparation on human lymphocyte proliferation in response to Cryptococcus neoformans Infect Immun, 61, pp. 464-469.
26. Caraher, EM and Parenteau, M and Gruber, H and Scott, FW. (2000) Flow cytometric analysis of intracellular IFN-gamma, IL-4 and IL-10 in CD3(+)4(+) T-cells from rat spleen J Immunol Methods, 244, pp. 29-40.
27. Stinn, JL and Taylor, MK and Becker, G and (1998) Interferon-gamma-secreting T-cell populations in rejecting murine cardiac allografts: Assessment by flow cytometry Am J Pathol, 153, pp. 1383-1392.
28. Archer, S. (1993) Measurement of nitric oxide in biological models FASEB J, 7, pp. 349-360.
29. McDonnell, JM and Hutchins, GM. (1985) Pulmonary cryptococcosis Hum Pathol, 16, pp. 121-128.
30. Schneerson-Porat, S and Shahar, A and Aronson, M. (1965) Formation of histiocyte rings in response to Cryptococcus neoformans infection RES J Reticuloendothel Soc, 2, pp. 249-255.
31. Fromtling, RA and Shadomy, HJ. (1986) An overview of macrophage-fungal interactions MycopathologIía, 93, pp. 77-93.
32. Hill, JO. (1992) CD4+ T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract J Exp Med, 175, pp. 1685-1695.
33. Diamond, RD and Bennett, JE. (1974) Prognostic factors in cryptococcal meningitis Ann Intern Med, 80, pp. 176-181.
34. Tucker, SC and Casadevall, A. (2002) Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm Proc Natl Acad Sci USA, 99, pp. 3165-3170.
35. Aguirre, K and Havell, DA and Gibson, GW and Johnson, LL. (1995) Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice Infect Immun, 63, pp. 1725-1731.
36. Hoag, KA and Lipscomb, MF and Izzo, AA and Street, NE. (1997) IL12 and INF gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C. B-17 mice Am J Respir Cell Mol Biol, 17, pp. 733-739.
37. Kawakami, K and Tohyama, M and Qifeng, X and Saito, A. (1997) Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: Effects of interleukin-12 Infect Immun, 65, pp. 1307-1312.
38. Janeway CA, TraversP. Immunobiology. The Immune System in Health and Disease. 2nd ed. New York: Garland Publishing Inc. 1996.
39. Hidore, MR and Nabavi, N and Sonleitner, F and Murphy, JW. (1991) Murine natural killer cells are fungicidal to Cryptococcus neoformans Infect Immun, 59, pp. 1747-1754.
40. Janeway CA, Travers P, Walport M, Capra DJ (eds). T-cell mediated immunity. In: Immunobiology: The Immune System in Health and Disease, 4th ed, London: Elsevier, 1999; 263-305.
41. Morani, C and Retini, C and Palazzetti, B and Bistoni, F and Vecchiarelli, A. (1997) Regulatory role of exogenous IL10 in the development of immune response versus Cryptococcus neoformans Clin Exp Immunol, 109, pp. 242-247.
42. Akdis, CA and Blesken, T and Akdis, M and Wuthrich, B and Blaser, K. (1998) Role of interleukin 10 in specific immunotherapy J Clin Invest, 102, pp. 98-106.
43. Masih, DT and Rubinstein, HR and Sotomayor, CE and Ferro, ME and Riera, CM. (1986) Non-specific immunosuppression in experimental cryptococcosis in rats Mycopathol, 94, pp. 79-84.
44. Sotomayor, CE and Rubinstein, HR and Riera, CM and Masih, DT. (1987) Immunosuppression in experimental cryptococcosis in rats. Induction of afferent T suppressor cells to a non-related antigen J Med Vet Mycol, 65, pp. 67-75.
45. Masih, DT and Sotomayor, CE and Rubinstein, HR and Riera, CM. (1999) Immunosuppression in experimental cryptococcosis in rats. Induction of efferent T suppressor cells to a non-related antigen Mycopathol, 144, pp. 179-186.
46. Taniguchi, M and Nakayama, T. (2000) Recognition and function of Valpha14 NKT cells Semin Immunol, 12, pp. 543-550.
47. Godfrey, DI and Hammond, KJ and Poulton, LD and Smyth, MJ and Baxter, AG. (2000) NKT cells: Facts, functions and fallacies Immunol Today, 21, pp. 573-583.
48. Kawakami, K and Kinjo, Y and Yara, S and (2000) Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans Infect Immun, 69, pp. 213-220.
49. Mitchell, TG and Perfect, JR. (1992) Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans Clin Microbiol Rev, 8, pp. 515-548.
50. Chaturvedi, V and Wong, B and Newman, SL. (1996) Oxidative killing of Cryptococcus neoformans by human neutrophils. Evidence that fungal mannitol protects by scavenging reactive oxygen intermediates J Immunol, 156, pp. 3836-3840.
51. Alspaugh, JA and Granger, DL. (1991) Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis Infect Immun, 59, pp. 2291-2296.
52. Yoshida, K and Akaike, T and Doi, T and (1993) Pronounced enhancement of.NO-dependent antimicrobial action by an.NO-oxidizing agent, imidazolineoxyl N-oxide Infect Immun, 61, pp. 3552-3555.
53. Lovchik, JA and Lyons, CR and Lipscomb, MF. (1995) A role for gamma interferon-induced nitric oxide in pulmonary clearance of Cryptococcus neoformans Am J Respir Cell Mol Biol, 13, pp. 116-124.
54. Lovchik, J and Lipscomb, M and Lyons, CR. (1997) Expression of lung inducible nitric oxide synthase protein does not correlate with nitric oxide production in vivo in a pulmonary immune response against Cryptococcus neoformans J Immunol, 158, pp. 1772-1778.
55. Kawakami, K. (2004) Regulation by innate immune T lymphocytes in the host defense against pulmonary infection with Cryptococcus neoformans Jpn J Infect Dis, 57, pp. 137-145.
56. Rayhane, N and Fitting, C and Lortholary, O and Dromer, F and Cavaillon, JM. (2000) Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection Infect Immun, 68, pp. 3748-3753.
57. Delfino, D and Cianci, L and Migliardo, M and (1996) Tumor necrosis factor-inducing activities of Cryptococcus neoformans components Infect Immun, 64, pp. 5199-5204.
58. Monari, C and Bistoni, F and Casadevall, A and (2005) Glucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages J Infect Dis, 191, pp. 127-137.
59. Murphy, JW and Cozad, GC. (1972) Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique Infect Immun, 5, pp. 896-901.
60. Retini, C and Vecchiarelli, A and Monari, C and Bistoni, F and Kozel, TR. (1998) Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes Infect Immun, 66, pp. 664-669.